Recent studies show that HIV patients are 10 to 20 times more likely to develop lymphoma compared to individuals without HIV.

This is the cold season, and many people are down with runny nose, fever, cough, and tiredness. However, according to experts ...

Combination Targeted Treatment Produces Lasting Remissions in People With Resistant Aggressive B-Cell Lymphoma June 19, 2024 — Researchers have developed a non-chemotherapy treatment regimen ...

The FDA has approved a new three-drug combination to treat certain types of an aggressive blood cancer called large B-cell lymphoma (LBCL).

Researchers explore the cellular and molecular adaptations associated with human secondary lymphoid tissue in adults during ...

Primary Effusion Lymphoma (PEL) is a rare and aggressive form of B-cell lymphoma that typically manifests in body cavities, leading to the accumulation of fluid (effusions) without the presence of ...

The direct antiglobulin test was positive for anti-C3d specificity, with cold agglutinin titer confirming the diagnosis of CAD.

Over time, you could have swollen lymph nodes, a fever, a tired feeling, belly pain, night sweats, weight loss, or more frequent infections. You're more likely to get CLL if you're middle-aged or ...

Ann LaCasce, MD, MMSc, director of the Dana-Farber/Massachusetts General Brigham Fellowship in Hematology/Oncology, ...

Common adverse events (AEs) included rash; COVID-19; fatigue; headache; upper respiratory tract infection; pyrexia ... Calquence provides a critical new treatment option to mantle cell lymphoma ...